Actively Recruiting
Randomized Study of Probiotic, Postbiotic, or Placebo Effects on Gut Microbiome During Antibiotic Use
Led by The Archer-Daniels-Midland Company · Updated on 2026-10-28
126
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating how a probiotic or postbiotic affects the gut microbiome in healthy adults who are receiving antibiotic treatment. This study focuses on understanding changes in the gut bacteria composition during antibiotic use and compares these effects to a placebo. The trial is conducted in Greece and recruits healthy adults aged 18 to 65 years. Participants are randomly assigned to one of three groups one group receives a probiotic containing live bacteria, another group receives a postbiotic containing heat-inactivated bacteria, and the third group receives a placebo. Each participant takes two capsules once daily for 28 days. The study is triple-blind, meaning neither participants nor researchers know who receives which treatment during the trial. During the study, participants undergo gut microbiome assessments at multiple time points including days 0, 3, 7, 14, 28, and 56 to measure changes in bacterial composition and gene abundance. Researchers also monitor gastrointestinal symptoms and assess safety and tolerability using questionnaires. The main outcome is the change in gut microbiome composition between baseline and day 14 compared to placebo. Participation lasts approximately 56 days to include follow-up evaluations.
CONDITIONS
Brief Title
Effect of a Probiotic or Postbiotic on Gut Microbiome During Antibiotic Treatment
Research Team
A
ADM Medical Team
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here